Can we establish a hierarchy among trastuzumab biosimilar candidates?

af Pivot, Xavier, Petit, Thierry
Udgivet i Br J Cancer (2018)

Subgroup analysis of patients with HER2-negative metastatic breast cancer in the second-line setting from a phase 3, open-label, randomized study of eribulin mesilate versus capeci...

af Pivot, Xavier, Im, Seock Ah, Guo, Matthew, Marmé, Frederik
Udgivet i Breast Cancer (2018)

Adjuvant Trastuzumab Is Required in Human Epidermal Growth Factor Receptor 2-Positive Node-Negative Breast Cancer Patients Regardless of Tumour Size

af Bender, Laura, Kurtz, Jean-Emmanuel, Petit, Thierry, Pivot, Xavier
Udgivet i J Breast Cancer (2020)

Biologic Drug Quality Assurance to Optimize HER2 + Breast Cancer Treatment: Insights from Development of the Trastuzumab Biosimilar SB3

af Lüftner, Diana, Lyman, Gary H., Gonçalves, João, Pivot, Xavier, Seo, Minji
Udgivet i Target Oncol (2020)

Correction to: Biologic Drug Quality Assurance to Optimize HER2+ Breast Cancer Treatment: Insights from Development of the Trastuzumab Biosimilar SB3

af Lüftner, Diana, Lyman, Gary H., Gonçalves, João, Pivot, Xavier, Seo, Minji
Udgivet i Target Oncol (2020)

Evaluating the clinical effectiveness and safety of various HER2-targeted regimens after prior taxane/trastuzumab in patients with previously treated, unresectable, or metastatic H...

af Paracha, Noman, Reyes, Adriana, Diéras, Véronique, Krop, Ian, Pivot, Xavier, Urruticoechea, Ander
Udgivet i Breast Cancer Res Treat (2020)

MAINTENANCE HORMONAL TREATMENT IMPROVES PROGRESSION FREE SURVIVAL AFTER A FIRST LINE CHEMOTHERAPY IN PATIENTS WITH METASTATIC BREAST CANCER

af Dufresne, Armelle, Pivot, Xavier, Tournigand, Christophe, Facchini, Thomas, Alweeg, Thierry, Chaigneau, Loic, De Gramont, Aimery
Udgivet 2008

Organizing medical oncology care at a regional level and its subsequent impact on the quality of early breast cancer management: a before-after study

af Voidey, Aline, Pivot, Xavier, Woronoff, Anne-Sophie, Nallet, Gilles, Cals, Laurent, Schwetterle, Francis, Limat, Samuel
Udgivet 2014

A time and motion study of subcutaneous versus intravenous trastuzumab in patients with HER2‐positive early breast cancer

af De Cock, Erwin, Pivot, Xavier, Hauser, Nik, Verma, Sunil, Kritikou, Persefoni, Millar, Douglas, Knoop, Ann
Udgivet i Cancer Med (2016)

A phenotypic and mechanistic perspective on heterogeneity of HER2-positive breast cancers

af Ferrari, Anthony, Sertier, Anne-Sophie, Vincent-Salomon, Anne, Pivot, Xavier, Pauporté, Iris, Saintigny, Pierre, Birnbaum, Daniel, Viari, Alain
Udgivet i Mol Cell Oncol (2016)

Intra-operative intra-peritoneal chemotherapy with cisplatin in patients with peritoneal carcinomatosis of ovarian cancer

af Guardiola, Emmanuel, Delroeux, Delphine, Heyd, Bruno, Combe, Marielle, Lorgis, Veronique, Demarchi, Martin, Stein, Ulrich, Royer, Bernard, Chauffert, Bruno, Pivot, Xavier
Udgivet 2009

A phase 2 randomized trial to evaluate the impact of a supervised exercise program on cardiotoxicity at 3 months in patients with HER2 overexpressing breast cancer undergoing adjuv...

af Jacquinot, Quentin, Meneveau, Nathalie, Chatot, Marion, Bonnetain, Franck, Degano, Bruno, Bouhaddi, Malika, Dumoulin, Gilles, Vernerey, Dewi, Pivot, Xavier, Mougin, Fabienne
Udgivet i BMC Cancer (2017)

Real-world patient-reported outcomes of women receiving initial endocrine-based therapy for HR+/HER2− advanced breast cancer in five European countries

af Davie, Alison, Carter, Gebra Cuyun, Rider, Alex, Pike, James, Lewis, Katie, Bailey, Abigail, Price, Gregory L., Ringeisen, Francois, Pivot, Xavier
Udgivet i BMC Cancer (2020)

Safety and Efficacy of Cabazitaxel in the Docetaxel-Treated Patients with Hormone-Refractory Prostate Cancer

af Calcagno, Fabien, Nguyen, Thierry, Dobi, Erion, Villanueva, Cristian, Curtit, Elsa, Kim, Stefano, Montcuquet, Philippe, Kleinclauss, François, Pivot, Xavier, Thiery-Vuillemin, Antoine
Udgivet 2012

Cisplatin/gemcitabine or oxaliplatin/gemcitabine in the treatment of advanced biliary tract cancer: a systematic review

af Fiteni, Frédéric, Nguyen, Thierry, Vernerey, Dewi, Paillard, Marie-Justine, Kim, Stefano, Demarchi, Martin, Fein, Francine, Borg, Christophe, Bonnetain, Franck, Pivot, Xavier
Udgivet i Cancer Med (2014)

Subcutaneous vs Intravenous Trastuzumab for Patients With ERBB2-Positive Early Breast Cancer: Final Analysis of the HannaH Phase 3 Randomized Clinical Trial

af Jackisch, Christian, Stroyakovskiy, Daniil, Pivot, Xavier, Ahn, Jin Seok, Melichar, Bohuslav, Chen, Shin-Cheh, Meyenberg, Christoph, Al-Sakaff, Nedal, Heinzmann, Dominik, Hegg, Roberto
Udgivet i JAMA Oncol (2019)

Beliefs and behavior regarding e-cigarettes in a large cross-sectional survey

af Couraud, Sébastien, Cortot, Alexis B., Pivot, Xavier B., Touboul, Chantal, Lhomel, Christine, Blay, Jean-Yves, Eisinger, François, Viguier, Jérôme, Morère, Jean-François, Greillier, Laurent
Udgivet i Prev Med Rep (2018)

Adjuvant Subcutaneous Trastuzumab for HER2‐Positive Early Breast Cancer: Subgroup Analyses of Safety and Active Medical Conditions by Body Weight in the SafeHer Phase III Study

af Jung, Kyung Hae, Ataseven, Beyhan, Verrill, Mark, Pivot, Xavier, De Laurentiis, Michelino, Al‐Sakaff, Nedal, Lauer, Sabine, Shing, Mona, Gligorov, Joseph, Azim, Hamdy A.
Udgivet i Oncologist (2018)

Dendritic cell and natural killer cell cross-talk: a pivotal role of CX3CL1 in NK cytoskeleton organization and activation

af Pallandre, Jean R., Krzewski, Konrad, Bedel, Romain, Ryffel, Bernhard, Caignard, Anne, Rohrlich, Pierre Simon, Pivot, Xavier, Tiberghien, Pierre, Zitvogel, Laurence, Strominger, Jack L., Borg, Christophe
Udgivet 2008

Efficacy of trabectedin in metastatic solitary fibrous tumor

af Chaigneau, Loïc, Kalbacher, Elsa, Thiery-Vuillemin, Antoine, Fagnoni-Legat, Christine, Isambert, Nicolas, Aherfi, Lionel, Pauchot, Julien, Delroeux, Delphine, Servagi-Vernat, Stephanie, Mansi, Laura, Pivot, Xavier
Udgivet 2011